These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of adriamycin and macrophage-toxic agents on lymphoma growth in lethally irradiated mice. Kobayashi Y; Taubman SB; Catanzaro PJ Gan; 1982 Oct; 73(5):833-40. PubMed ID: 6299872 [No Abstract] [Full Text] [Related]
5. Antigenic characterization of heterozygous mouse lymphomas after immunoselection in vivo. Bjaring B; Klein G J Natl Cancer Inst; 1968 Dec; 41(6):1411-29. PubMed ID: 4882575 [No Abstract] [Full Text] [Related]
6. Impaired growth of a radiation-induced lymphoma in intact or lethally irradiated allogeneic athymic (nude) mice. Bonmassar E; Campanile F; Houchens D; Crino L; Goldin A Transplantation; 1975 Oct; 20(4):343-6. PubMed ID: 1162722 [No Abstract] [Full Text] [Related]
7. Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis. Bremberg S; Klein E; Stjernswärd J Cancer Res; 1967 Nov; 27(11):2113-8. PubMed ID: 4294531 [No Abstract] [Full Text] [Related]
8. Depression of antilymphoma allograft reactivity by tumor-associated factors. Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118 [No Abstract] [Full Text] [Related]
9. Site-dependent differences in rejection of tumor cells with and without preimmunization. den Otter W; Runhaar BA; Ruitenbeek A; Dullens HF Eur J Immunol; 1974 Jun; 4(6):444-6. PubMed ID: 4471634 [No Abstract] [Full Text] [Related]
10. Effect of immunopharmacologic treatment on anti-tumor immune response in lethally irradiated mice. Riccardi C; Santoni A; Puccetti P Boll Soc Ital Biol Sper; 1978 Aug; 54(15):1417-23. PubMed ID: 743444 [No Abstract] [Full Text] [Related]
11. Dose-dependent recognition of irradiated isogeneic mouse lymphoma cells: study by terminal dilution assay. Maruyama Y Int J Cancer; 1968 Sep; 3(5):593-602. PubMed ID: 5724525 [No Abstract] [Full Text] [Related]
14. Immunological enhancement of a murine allogeneic lymphoma. Pasqualini CD; Colmerauer ME Medicina (B Aires); 1976; 36(3):189-92. PubMed ID: 966987 [No Abstract] [Full Text] [Related]
15. Studies on the mechanism of isoantigenic variant formation in heterozygous mouse tumors. IV. H-2 component analysis of an (A-Sn x A.SW)F1 lymphoma. Ozer HL; Klein G; Ozer JH J Natl Cancer Inst; 1966 Feb; 36(2):233-47. PubMed ID: 5325483 [No Abstract] [Full Text] [Related]
16. Effect of syngeneic RNA pretreatment on the growth of an allogeneic mouse tumor. Comerauer ME; Dosne Pasqualini C Acta Physiol Lat Am; 1976; 26(2):150-3. PubMed ID: 1030178 [No Abstract] [Full Text] [Related]
17. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse]. Piazzon I; Déroche A; Matusevich M; Pasqualini CD Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002 [No Abstract] [Full Text] [Related]
18. Variation in survival time of mice receiving x-irradiated murine lymphoma cells. Maruyama Y Br J Radiol; 1966 Oct; 39(466):740-3. PubMed ID: 5927192 [No Abstract] [Full Text] [Related]
19. Antibody-mediated suppression of grafted lymphoma cells. I. Participation of a host factor(s) other than complement. Shin HS; Kaliss N; Borenstein D Proc Soc Exp Biol Med; 1972 Feb; 139(2):684-9. PubMed ID: 5059065 [No Abstract] [Full Text] [Related]
20. [Prevention of tumor growth by immunization of hamsters with x-irradiated SV40-transformed cells]. Ashkenazi A; Zadik Z Harefuah; 1969 Nov; 77(9):376-9. PubMed ID: 4320099 [No Abstract] [Full Text] [Related] [Next] [New Search]